Project Grant R61HD123542
- The National Institute of Child Health and Human Development awarded The Washington University $922,870 on July 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865, Assistance Listing 93.HDR). The award funds research to define the molecular mechanisms by which age-associated increases in ovarian tissue stiffness drive follicle inflammation and impair oocyte quality and fertility. The research tests the hypothesis that follicles detect age-related...
- The National Institute of Child Health and Human Development awarded The Washington University $427,625 on August 25, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to investigate ubiquitination as a mechanism to improve oxytocin receptor responsiveness and uterotonic therapies in postpartum hemorrhage. The research addresses oxytocin receptor desensitization induced by prolonged oxytocin exposure—a barrier to effective labor management and...
- The National Institute of Child Health and Human Development awarded The Washington University $135,378 on August 26, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to investigate the role of maternal gut bacteria in fetal growth and placental development. The research defines bacterial metabolic pathways that influence fetal growth through immune cell function at the maternal-fetal interface, with specific focus on macrophages in placental villi and...
- The National Institute of Child Health and Human Development awarded The Washington University $427,625 on May 15, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to investigate retinoic acid signaling and uterine epithelial cell fate determination. The research examines how retinoic acid signaling maintains uterine epithelial cell identity during adult homeostasis and tests hypotheses about the antagonistic relationship between retinoic acid and...
- The National Institute of Child Health and Human Development awarded Worcester Polytechnic Institute $555,371 on June 1, 2026, to develop bioengineered in vitro models of uterine fibroids under the Child Health and Human Development Extramural Research program (CFDA 93.865). The funded work creates two novel in vitro platforms—one with tunable transport properties and one modeling intramural uterine fibroids surrounded by myometrium—to study how altered signaling from sex hormones (estrogen...
- The National Institute of Child Health and Human Development awarded The Washington University $619,913 through the Child Health and Human Development Extramural Research program (CFDA 93.865) on May 15, 2026. The award funds research investigating how temperature and polyamines regulate CatSper, a sperm-specific calcium channel critical to male fertility. The project will test the hypothesis that human CatSper activation is controlled by four key factors—pH, temperature, polyamines, and...
- The National Institute of Child Health and Human Development, part of the Department of Health and Human Services National Institutes of Health, awarded $456,500 to The University of Texas Southwestern Medical Center on June 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865). The award funds molecular characterization of human pregnancy-induced cervical epithelium through two research aims. First, the recipient will apply single-cell and spatial...
- The National Institute of Child Health and Human Development awarded the University of Missouri System $411,539 on May 15, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to conduct functional assessment of extracellular vesicles from the female reproductive tract during early pregnancy. The research uses oviductal epithelial cell-specific CD9-green fluorescent protein reporter mice to visualize and track maternal extracellular vesicles within...
- The National Institute of Child Health and Human Development awarded University of California, San Diego $440,000 on September 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to investigate uterine neuronal innervation dynamics and immune function during the peripartum period. The research maps sympathetic, parasympathetic, and sensory neuronal subtypes across uterine layers in mice, describing their spatial and temporal distribution with proteomic...
- The National Institute of Child Health and Human Development, a component of the Department of Health and Human Services, awarded Northwestern University $684,253 on September 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to investigate transcriptional and epigenome dysregulation in uterine leiomyomas. The research integrates advanced molecular and genomic technologies, bioinformatics, and a patient-derived precision-cut ex vivo tissue explant...
The National Institute of Child Health and Human Development awarded The Washington University $396,259 on September 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to develop and validate uterine peristalsis imaging (UPI), a noninvasive diagnostic technology that provides objective, quantitative measurements of uterine peristalsis to predict frozen embryo transfer outcomes. Approximately 200,000 patients undergo frozen embryo transfer annually in the United States, with success rates remaining at approximately 60% despite high-quality embryos and correct timing. Current uterine receptivity assessment focuses on endometrial properties while neglecting myometrial contractile function, despite evidence that excessive uterine peristalsis reduces pregnancy rates by approximately 50 percent. The project will develop UPI to noninvasively and quantitatively assess uterine peristalsis during the frozen embryo transfer procedure, with preliminary data demonstrating that aberrant directional patterns of uterine peristalsis predict pregnancy outcomes. Performance occurs at The Washington University's Office of Sponsored Research Services in St. Louis, Missouri. The period of performance runs from September 1, 2026, through August 31, 2028. The assistance type is a Project Grant.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $396.3k | 9/3/26 |